Company Filing History:
Years Active: 2017
Title: Innovations in Complement Modulation by Jonathan P Hannan
Introduction
Jonathan P Hannan is an accomplished inventor based in Arvada, Colorado. He has made significant contributions to the field of complement modulation through his innovative research and patent work. His expertise lies in developing targeted delivery systems for complement activity modulators.
Latest Patents
Hannan holds a patent for "Complement receptor 2 (CR2) targeting groups." This patent describes compositions and methods directed to soluble proteins that can selectively deliver modulators of complement activity. The targeted delivery is achieved by selectively mutating specific amino acids in a targeting protein portion of the composition, which corresponds to the first two N-terminal SCR domains of CR2. Depending on the combination of mutations introduced, a complement activity modulator can be selectively delivered to specific ligands of CR2 at sites where activation or suppression of the complement system is desired. Hannan's work in this area has the potential to advance therapeutic strategies in various medical applications.
Career Highlights
Hannan is affiliated with the University of Colorado, where he continues to engage in groundbreaking research. His work has garnered attention for its innovative approach to complement modulation, which is crucial for developing new treatments for diseases related to the immune system.
Collaborations
Hannan collaborates with notable colleagues, including James M Kovacs and V Michael Holers. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field of complement biology.
Conclusion
Jonathan P Hannan's contributions to the field of complement modulation through his innovative patent work exemplify the impact of targeted delivery systems in medical research. His ongoing work at the University of Colorado continues to pave the way for future advancements in therapeutic applications.